SIMRIS B Share Price | Simris Group AB Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Poor long term growth as Operating profit has grown by an annual rate -12.66% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK Million (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-6.04

Return on Equity

204.99%

Price to Book

0.00

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Jun 2025)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

15.83%

6 Months

107.18%

1 Year

-20.63%

2 Years

-59.33%

3 Years

-46.28%

4 Years

-75.26%

5 Years

-81.5%

Simris Group AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.34%

EBIT Growth (5y)

-12.66%

EBIT to Interest (avg)

-14.76

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-79.81

Sales to Capital Employed (avg)

0.08

Tax Ratio

10.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-2.99

EV to EBITDA

-6.89

EV to Capital Employed

1.09

EV to Sales

34.75

PEG Ratio

Dividend Yield

ROCE (Latest)

-36.58%

ROE (Latest)

378.90%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 250.00% vs -80.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -21.67% vs 37.50% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.20",
          "chgp": "250.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.00",
          "val2": "-3.70",
          "chgp": "18.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.30",
          "val2": "-6.00",
          "chgp": "-21.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9,783.10%",
          "val2": "-45,836.50%",
          "chgp": "3,605.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -34.09% vs 7.32% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.24% vs -52.87% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.90",
          "val2": "4.40",
          "chgp": "-34.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.90",
          "val2": "-23.20",
          "chgp": "22.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "4.00",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-34.60",
          "val2": "-37.30",
          "chgp": "7.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11,341.50%",
          "val2": "-8,597.40%",
          "chgp": "-274.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.70

0.20

250.00%

Operating Profit (PBDIT) excl Other Income

-3.00

-3.70

18.92%

Interest

1.50

0.00

Exceptional Items

0.00

Consolidate Net Profit

-7.30

-6.00

-21.67%

Operating Profit Margin (Excl OI)

-9,783.10%

-45,836.50%

3,605.34%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 250.00% vs -80.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -21.67% vs 37.50% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2.90

4.40

-34.09%

Operating Profit (PBDIT) excl Other Income

-17.90

-23.20

22.84%

Interest

3.50

4.00

-12.50%

Exceptional Items

-2.20

0.00

Consolidate Net Profit

-34.60

-37.30

7.24%

Operating Profit Margin (Excl OI)

-11,341.50%

-8,597.40%

-274.41%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -34.09% vs 7.32% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 7.24% vs -52.87% in Dec 2023

All Annual Results

Company CV

About Simris Group AB

Simris Group AB

Pharmaceuticals & Biotechnology

Simris Alg AB is a Sweden-based company, which is primarily engaged in the special foods and wellbeing products industry. The Company operates as a manufacturer of dietary supplements and specialty foods. The Company's products are based on algae-plants that live in water, such as seaweed, phytoplankton and kelp. These products are rich of Omega-3 oils and made from natural ingredients. The Company offers a wide range of algae-based supplements and foods, among them are Simris Algae Omega-3 Original, Simris Algae Omega-3 for Mothers, Simris Algae Omega-3 for Athletes, Finest Chlorella, Sundried Spirulina, Boosting Astaxanthin, Chlorella Crispies, Flower Power Algae Tea, Sun Candy Algae Tea and other.

Company Coordinates

Company Details

Herrestadsvagen 24, Hammenhog , None : 276 50

Tel: 46 414 445050

https://simrisalg.se/

Registrar Details